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Mos is a serine±threonine protein kinase and a key regulator of meiosis. One function of Xenopus Mos is to activate
mitogen-activated protein kinase (MAPK) through direct phosphorylation and activation of MAPK kinase (MAPKK). All
three members of this signal cascade can individually induce hormone-independent reentry of oocytes into meiosis I.
However, their inducing ef®ciency is reduced in the absence of protein synthesis. Here we show that de novo Mos
synthesis is required for induction of meiosis I by active MAPKK or Mos±MAPK coinjection. In addition, MAPK ef®ciently
phosphorylates Mos at Ser-3 in vitro. These results suggest that a positive feedback loop exists between MAPK and Mos
during oocyte maturation. De novo synthesis of Mos, and other proteins, is required for progression from meiosis I to the
metaphase arrest at meiosis II; therefore, one function of MAPK during normal Xenopus oocyte maturation might be to
stimulate the synthesis or accumulation of Mos that is required for the completion of meiosis. q 1996 Academic Press, Inc.
INTRODUCTION MPF, including Raf-1 (Fabian et al., 1993), ribosomal S6
kinase (Erikson and Maller, 1986), mitogen-activated pro-
tein kinase (MAPK) (Ferrell et al., 1991; Gotoh et al., 1991a;Xenopus laevis oocytes are naturally arrested in late G2
Posada et al., 1991), and MAPK kinase (MAPKK, or MEK)of the ®rst meiotic prophase. Progesterone exposure induces
(Matsuda et al., 1992).completion of meiosis I, which is marked by germinal vesi-
Immature Xenopus oocytes contain a store of inactivecle breakdown (GVBD), chromosome condensation, meiotic
cyclin Bp34cdc2 (pre-MPF), which requires newly synthe-spindle formation, and extrusion of the ®rst polar body, a
sized proteins for its activation (Masui and Markert, 1971;process that usually takes 3±6 hr. A brief meiotic interphase
Smith and Ecker, 1971). One such protein is the c-mos pro-is followed by progression to meiosis II, where the mature
tooncogene product, a serine±threonine kinase that is nec-oocyte arrests in metaphase until fertilization. In amphibi-
essary and suf®cient for reinitiation of meiosis I (Sagata etans, reentry into meiosis I requires protein synthesis and
al., 1988; Freeman et al., 1989; Yew et al., 1992). Mos notinvokes a complex array of signal-transducing phosphoryla-
only triggers MPF activation, but also stimulates the MAPKtions and dephosphorylations (reviewed by Maller, 1990).
pathway by direct phosphorylation and activation ofMany of these phosphorylations occur just before entry into
MAPKK (Nebreda and Hunt, 1993; Posada et al., 1993; Shi-M-phase and correlate with activation of maturation-pro-
buya and Ruderman, 1993; Mansour et al., 1994a; Chenmoting factor (MPF), a complex of cyclin B and the serine±
and Cooper, 1995). The Mos±MAPK pathway also functionsthreonine kinase p34cdc2. All eukaryotes appear to require
during metaphase II arrest, where it is a required componentMPF activity for both meiotic and mitotic M-phase transi-
of cytostatic factor (CSF) (Sagata et al., 1989a; Haccard ettions (reviewed by Murray and Hunt, 1993). Many other
al., 1993).kinases are activated at approximately the same time as
The mechanism by which Mos initiates MPF activation
during meiosis I is not known. For instance, it is unclear
whether MAPK activation necessarily precedes MPF activa-1 The U.S. Government's right to retain a nonexclusive royalty-
tion. Some evidence supports a MAPK-dependent activationfree license in and to the copyright covering this paper, for govern-
of MPF (Muslin et al., 1993; Kosako et al., 1994a; Gotoh etmental purposes, is acknowledged.
al., 1995), while others have shown that progesterone can2 Present address: Department of Cellular Pathology, Armed
Forces Institute of Pathology, Washington, DC 20306-6000. induce GVBD in the absence of detectable MAPK activity
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(Fabian et al., 1993). To add to the confusion, progesterone- Mos Protein
induced activation of MAPK and MPF is temporally very
Wild-type and catalytically inactive (K90R) Mos protein wereclose (Ferrell et al., 1991; Gotoh et al., 1991a; Posada et al.,
puri®ed from bacteria as malE mosxe fusion products of approxi-
1991), yet, Mos protein begins to accumulate at least 2 hr mately 77 kDa (maltose-binding protein-Mos, or MBP Mos (Yew
earlier (Sagata et al., 1989b; Watanabe et al., 1989). et al., 1992)). Puri®ed proteins were dialyzed against injection
Several recent reports suggest that activation of the buffer (IB) containing 100 mM NaCl, 10 mM Hepes (pH 7.5), and
MAPK pathway is suf®cient to induce MPF activation in 1 mM dithiothreitol (DTT) and quanti®ed by Bradford assay (Brad-
Xenopus. High levels of gain-of-function MAPKKs (Gotoh ford, 1976, Bio±Rad Laboratories) in conjunction with Coomassie-
stained SDS±polyacrylamide gels. Injections were in 30- to 60-nlet al., 1995; Huang et al., 1995) or thiophosphorylated
volumes. For coinjection of Mos and MAPK, proteins were dilutedMAPK (Haccard et al., 1995) induce progesterone-indepen-
in IB and mixed at 47C immediately before injection. GVBD wasdent MPF activation and GVBD. However, the critical ques-
scored by the appearance of a white spot in the animal hemispheretions concerning the requirement for protein synthesis re-
and con®rmed in a subset of oocytes by manual dissection. In amain unanswered. Cycloheximide blocked MPF activation
given batch of oocytes where 1 ng of wild-type MBP Mos induced
upon microinjection of thiophosphorylated MAPK (Haccard no GVBD, a minimum of 4±6 ng of active MAPK was required for
et al., 1995) or activated STE11, a yeast MAPKK kinase the coinjection with 1 ng MBP Mos to achieve a minimum of 80%
(Gotoh et al., 1995). However, cycloheximide only partially GVBD.
inhibited MPF activation upon microinjection of constitu-
tively activated Xenopus MAPKK, providing the clearest
demonstration that a threshold level of speci®c activity is Mos Phosphorylation
needed in the absence of protein synthesis (Huang et al.,
Wild-type MBP Mos (MBP Moswt) and K90R Mos (MBP Moskm)1995). Here we analyze the protein synthesis requirement
were phosphorylated in 30-ml reactions (0.33 mg/ml Mos) containingat subthreshold levels of activated MAPK and MAPKK and
200 ng active wild-type MAPK. Reactions were carried out for 20
show that Mos is one of the required proteins. The results min at 307C in kinase buffer (KB) containing 50 mM Hepes (pH
provide direct evidence that a positive feedback loop exists 7.5), 5 mM MgCl, 2 mM DTT, 20 mM Na-ATP, 10 mg/ml aprotinin,
between MAPK and Mos. 10 mg/ml leupeptin, and 15 mCi of [g-32P]ATP (3000 Ci/mmole,
Amersham). Samples were resolved on 8±16% Novex Tris±glycine
polyacrylamide gels and phosphoproteins were visualized by auto-
radiography. 32P incorporation into Mos was quanti®ed by a phos-MATERIALS AND METHODS
phoimager. In a typical 20-min reaction, Mos (1 mg) contained
11,110 arbitrary units, myelin basic protein (1 mg) containedOocyte Injections 122,000 arbitrary units, and the background (in Mos) was 200; a
20-min reaction gave approximately half-maximal incorporation.Oocytes were isolated and injected as described (Matten and Vande
For tryptic phosphopeptide analysis, 100-ml reactions containingWoude, 1995). Brie¯y, X. laevis females were purchased from Xenopus
12 mg Mos and 1.5 mg active MAPK were carried out for 90 minI (Ann Arbor, MI) and oocytes were surgically removed. Stage VI
at 307C.oocytes were manually defolliculated then maintained at 187C in 50%
MBP was not signi®cantly phosphorylated by active MAPK inLeibovitz's L-15 medium (GIBCO) containing 5 mg/ml bovine serum
vitro, either as puri®ed protein or in the MBP Mos fusion product.albumin (Fraction V, protease free; Boehringer Mannheim Biochemi-
Two-dimensional tryptic phosphopeptide maps of MBP Moswt andcals). Injections and incubations with progesterone (10 mg/ml; Calbio-
Moswt (MBP Moswt cleaved with Factor Xa protease prior to phos-chem) or cycloheximide (10 mg/ml), as well as subsequent maturation,
phorylation by MAPK) were indistinguishable.were carried out at 21±237C.
Identi®cation of Mos Phosphorylation SitesMAPK and MAPKK
Both wild-type and catalytically inactive MAPK (K52R) were pu- 32P Mos or 32P MBP Mos from in vitro reactions with active
MAPK were analyzed by tryptic peptide mapping as described (Mor-ri®ed from bacterial cells in the form of (His)6-tagged rat ERK2 as
described (Robbins et al., 1993). Wild-type MAPK was activated in rison et al., 1993). Brie¯y, proteins were separated by SDS±poly-
acrylamide gel electrophoresis, eluted from the gel slice, precipi-vitro to a ®nal speci®c activity of 0.5 mmole/min/mg using MAPKK
puri®ed from rabbit skeletal muscle as described (Mansour et al., tated with trichloroacetic acid, and subjected to enzymatic diges-
tion with trypsin. For two-dimensional mapping on thin-layer1994b). Thiophosphorylated, wild-type MAPK was prepared in the
same manner except that reactions contained 2 mM ATPgS and cellulose plates, tryptic peptides were resolved by electrophoresis
at pH 1.9 in the ®rst dimension (30 min at 1000 V) and by chroma-were extended to 5 hr, 307C; the ®nal speci®c activity was approxi-
mately 0.2 mmole/min/mg. Constitutively active MAPKK mutant tography in the second dimension (n-butanol/pyridine/acetic acid/
water in the ratio 75/50/15/60; Boyle et al., 1991). Phosphopeptides(DN3-S218E-S222D), containing an activating N-terminal deletion
from residues 32 to 51 and amino acid substitutions at residues were visualized by a phosphoimager. For identi®cation of phosphor-
ylation sites, tryptic peptides were resolved by reverse-phase HPLC218 and 222 (Mansour et al., 1994a), was puri®ed from bacteria as
described (Mansour et al., 1994b) and further puri®ed to homogene- and sequenced by Edman degradation as described (Morrison et al.,
1993). Two-dimensional phosphoamino acid analysis was per-ity by Superose 12 chromatography. These mutations elevate
MAPKK activity to approximately 500-fold greater than basal wild- formed by thin-layer electrophoresis at pH 1.9 and 3.5 (Boyle et al.,
1991).type activity, as measured using MAPK (K52R) as substrate.
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Endogenous Mos Synthesis
Immediately following addition of progesterone or injection, oo-
cytes were incubated for 8 hr in 0.5 mCi 35S-Met/Cys (Pro-mix,
Amersham) per milliliter of modi®ed Barth's solution (Matten and
Vande Woude, 1995). Ten oocytes were homogenized in 0.1 ml
lysis buffer containing 10 mM Na phosphate (pH 7.5), 100 mM
NaCl, 50 mM NaF, 20 mM b-glycerophosphate (pH 7.5), 1 mM
EDTA, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, and
10 mg/ml each of leupeptin, aprotinin, pepstatin A, and phenyl-
methylsulfonyl ¯uoride. The homogenates were brought to 1.0 ml
with lysis buffer and centrifuged for 5 min, 47C, at 12,000g. After
a second centrifugation at 80,000g for 30 min, 47C, endogenous
Mos was immunoprecipitated using 5s mouse monoclonal anti-
body with or without Mos competing peptide (Watanabe et al.,
1989). Immunoprecipitated Mos was resolved on a 12% SDS±poly-
acrylamide gel and the labeled protein was visualized by ¯uorogra-
phy using a phosphoimager.
RESULTS
Microinjection of in vitro activated MAPK into Xenopus
oocytes is not suf®cient to induce reentry into meiosis I at
levels of MAPK that cause CSF arrest, unless a thiophosph-
orylated, stably activated MAPK is used (Haccard et al.,
1993, 1995). Since injected Mos induces rapid MAPKK and
MAPK activation (Posada et al., 1993; Matten et al., 1994),
we reasoned that coinjection of a limiting amount of Mos
protein with activated, but not thiophosphorylated, MAPK
might help maintain suf®cient total MAPK activity to in- FIG. 1. Induction of GVBD by Mos±MAPK coinjection requires
duce maturation. Microinjection of either Mos (1 ng) alone protein synthesis. (A) Oocytes were injected with the indicated
or up to 12 ng of activated MAPK alone did not induce any amounts of MBP Mosxe (Mos), in vitro activated MAPK (MAPK*), or
GVBD (Fig. 1). However, when 1 ng of Mos was coinjected unactivated MAPK (MAPK). The number of oocytes that achieved
with 6 ng of in vitro activated MAPK, GVBD was very ef®- GVBD relative to the total number injected is indicated at the
top. Progesterone (PG) and cycloheximide (CHX) were added to theciently induced (Fig. 1). We could not detect activated en-
culture medium at 10 mg/ml; CHX was added 1 hr prior to injection.dogenous MAPK after injection of 1 ng of Mos, and after
(B) Time course of GVBD induction from the same experiment asGVBD, total MAPK activity, measured in immune complex
in (A). Similar results were obtained in four independent experi-kinase assays, was the same under all conditions shown in
ments; the range of GVBD induced by these amounts of Mos±Fig. 1 (data not shown). Substituting nonactivated MAPK
MAPK* was 65±100%.
was much less effective, and preventing protein synthesis
with cycloheximide blocked induction of GVBD at these
levels of Mos and MAPK (Fig. 1).
These results indicate, not surprisingly, that Mos potenti- total incorporation of 32P into Moskm was always 40±50%
of Moswt, yet two-dimensional tryptic phosphopeptide mapsates the ability of MAPK to induce GVBD. However, the
results also allow the converse possibility, that is, a positive indicated that the same sites were phosphorylated in both
proteins (Fig. 2B). Two-dimensional phosphoamino acidfeedback signal from MAPK to Mos. The most direct signal
would be phosphorylation of Mos by MAPK, potentially analysis indicated that Mos was phosphorylated only on
serine, although longer exposures revealed a trace of phos-enhancing Mos function through increased catalytic ef®-
ciency or greater protein stability. To investigate these pos- phothreonine (data not shown). Sequence analysis of 32P
tryptic peptides from Moswt indicated phosphorylation atsibilities, we examined the ability of MAPK to phosphory-
late Mos in vitro. Activated MAPK ef®ciently catalyzed serines 3, 16, 26, and 158 (Figs. 2C and 3). All four sites
contain a proline residue in the /1 position, in agreementserine phosphorylation of Mos at a rate approximately 10-
fold slower than the commonly used in vitro substrate of with the minimal MAPK consensus phosphorylation se-
quence (Davis, 1993). We performed preliminary experi-MAPK, myelin basic protein (see Materials and Methods).
Both wild-type Mos and a K90R Mos mutant lacking kinase ments to determine if MAPK phosphorylation of Mos in
vitro affected Mos Kinase activity. Phosphorylated MBPactivity were phosphorylated by MAPK, but not in reactions
with catalytically inactive MAPK (Fig. 2A). Interestingly, Mos was immobilized on amylose resin and its kinase activ-
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steep. For example, where 2 ng of injected Mos produced
50% GVBD in 5.5 hr, 1 ng induced no GVBD after 8 hr,
indicating that only small increases in steady-state Mos
levels would be required (Matten and Vande Woude, unpub-
lished results). Third, the kinetics of induction by Mos±
MAPK are slower than those observed with progesterone
or higher levels of Mos alone, which may represent the time
necessary to initiate Mos synthesis (Fig. 1B). Fourth, the
MAPK phosphatase, MKP-1, blocks progesterone-induced
Mos synthesis (Gotoh et al., 1995). Last, thiophosphorylated
MAPK or Mos±MAPK coinjection induces progesterone-in-
dependent Mos synthesis (Fig. 4A). To directly test the re-
quirement for de novo Mos synthesis, we injected mos anti-
sense or sense oligonucleotides (Sagata et al., 1988) 2 hr
before Mos±MAPK coinjection. The antisense, but not the
sense, oligonucleotides blocked Mos±MAPK-induced
GVBD (Fig. 4B) and MPF activation (not shown).
Since MAPKK provides at least one entry point for Mos
into the MAPK pathway, injection of MAPKK should mimic
the features of Mos±MAPK coinjection. We demonstrated
this by injecting constitutively active MAPKK (Mansour et
al., 1994a), with and without pretreatment of oocytes with
cycloheximide. As shown with Xenopus Asp218, Asp222
MAPKK (Huang et al., 1995), GVBD and MPF activation
were inhibited by cycloheximide at a submaximal level of
constitutively activated MAPKK (data not shown). As with
Mos±MAPK coinjection, the kinetics of induction by
MAPKK were slower than those of induction by progester-FIG. 2. MAPK phosphorylates Mos in vitro. (A) In vitro kinase
one, and antisense mos oligonucleotides blocked MAPKK-assays with MBP Moswt (wt) and MBP-Moskm (km) containing in
vitro activated MAPK (lanes 1,3) or catalytically inactive MAPK induced GVBD (Fig. 4C). These results demonstrate that
(lanes 2, 4). The position of molecular weight markers (in kDa) is Mos synthesis is required for progesterone-independent ac-
shown on the left. The autoradiogram represents a 30-min exposure tivation of GVBD by a level of MAPKK suf®cient to induce
at room temperature. (B) Two-dimensional tryptic phosphopeptide up to 100% GVBD.
maps of MBP Moswt and MBP-Moskm phosphorylated by MAPK in
vitro. The direction of electrophoresis (horizontal axis) and the ori-
gin (o) are indicated. Essentially identical maps were obtained for
DISCUSSIONMoswt and Moskm, where the MBP moiety was cleaved prior to
phosphorylation by MAPK. (C) Reverse-phase HPLC analysis of
Constitutively activated MAPKK and MAPK can inducetryptic phosphopeptides from MBP Moswt phosphorylated by
oocyte maturation independently of progesterone. UsingMAPK in vitro. 32P cpm represents total 32P minus background in
each column fraction. Peak fractions (I, II, and III) were subjected antisense mos oligonucleotides, we show that one compo-
to Edman degradation (see Fig. 3). nent of their ability to induce GVBD is the stimulation of
Mos synthesis and that at the levels of protein used here,
MAPK and MAPKK are suf®cient for maturation only if
Mos synthesis is allowed. This result exposes a positive
feedback loop between the MAPK pathway and Mos. Feed-ity was assayed using as substrate a kinase-inactive MAPKK
mutant that also lacks two major MAPK phosphorylation back loops involving Mos, MAPKK, MAPK, and MPF have
been proposed previously (Roy et al., 1996; Haccard et al.,sites (K97M/T292A/T386A). Although no clear effects were
observed, this possibility in vitro cannot be excluded. Since 1995; Gotoh et al., 1995; Kosako et al., 1994b). Our data
demonstrate that Mos is a critical component of the feed-Mos phosphorylation in oocytes occurs predominantly on
Ser-3 (Freeman et al., 1992), these results imply that MAPK back generated by the MAPK pathway.
Activation of the MAPK pathway could stimulate decould act as a Mos kinase in vivo.
Another way that activated MAPK could enhance the novo Mos synthesis by several routes. One possibility is
via MAPK phosphorylation of a Xenopus ribosomal S6induction of GVBD by Mos is to enhance synthesis or accu-
mulation of Mos. This possibility is supported by several kinase isoform; however, direct evidence linking S6 ki-
nase to increased protein synthesis is lacking (Maller,observations. First, induction of GVBD by Mos±MAPK
coinjection requires protein synthesis (Fig. 1). Second, the 1990). Another possibility is through regulation of c-mos
mRNA polyadenylation, which helps to mediate proges-threshold for induction of GVBD by injected Mos is very
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FIG. 3. MAPK phosphorylates Mos in vitro at four serine residues. The tryptic phosphopeptide isolated in each HPLC peak fraction (I,
II, and III; shown in Fig. 2) was subjected to Edman degradation. Ser-26 was con®rmed by digestion of an aliquot of HPLC peak fraction
III with Asp-N, followed by Edman degradation. The Xenopus c-Mos amino acid sequence, including the junction with maltose binding
protein (MBP), is shown at the bottom.
terone-induced Mos synthesis during meiotic maturation therefore, a direct role for PHAS-I in MAPK-induced pro-
tein synthesis remains to be demonstrated. Nonetheless,(Sheets et al., 1995). How MAPK might trigger the polyad-
enylation machinery is unknown. During normal matura- since the initiation phase of translation is generally rate
limiting (Hershey, 1991), this is an attractive mechanismtion, the polyadenylation system presumably operates in-
dependently of MAPK and MPF, since Mos synthesis be- to explain MAPK's ability to stimulate Mos synthesis un-
der the conditions described here. In a previous study, wegins well before their activation (Sheets et al., 1995). In
the feedback loop proposed here, however, both MAPK found that microinjection of the cAMP-dependent protein
kinase catalytic subunit (PKA), at levels that block pro-and MPF could be involved.
Another possibility was described in recent studies of gesterone-induced Mos translation, do not prevent in-
jected Mos from activating endogenous MAPK (Matteninsulin-stimulated phosphorylation events in rat adipo-
cytes (Haystead et al., 1994; Lin et al., 1994; Pause et et al., 1994). This suggests that PKA can inhibit protein
synthesis at a point(s) downstream of MAPK, perhaps be-al., 1994), where MAPK phosphorylates PHAS-I (the rat
homologue of human 4EBP1) and releases PHAS-I's inhi- tween MAPK and the polyadenylation apparatus or the
translation initiation complex.bition of mRNA cap-dependent translation initiation.
After exposure of oocytes to progesterone or after injec- In addition to stimulating Mos synthesis, MAPK could
also regulate Mos by direct phosphorylation. This possibil-tion of activated MAPK, we observed the accumulation
of higher-molecular-weight forms of PHAS-I that is asso- ity is supported by the in vitro phosphorylation data de-
scribed here, as well as the pattern and function of Mosciated with PHAS-I phosphorylation (Lin et al., 1994)
(data not shown). However, the difference between phosphorylation during oocyte maturation. For example,
Mos is phosphorylated only on serine residues and predomi-treated and untreated Stage VI oocytes ranged from indis-
tinguishable to severalfold in separate experiments; nantly at Ser-3 (Freeman et al., 1992). The kinase responsi-
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required for the normal hyperphosphorylation of Mos (Nis-
hizawa et al., 1992). This proline residue at the /1 position
is absolutely conserved in the MAPK consensus phosphory-
lation sequence (Davis, 1993), as well as in all four sites in
Mos that we found in vitro (Fig. 3). Of the other known
kinases activated at approximately the same time as MAPK,
only cyclin Bp34cdc2 has a consensus phosphorylation se-
quence similar to MAPK, and active cyclin B-p34cdc2 does
not signi®cantly phosphorylate Mos in vitro (Nishizawa et
al., 1992; Matten and Vande Woude, unpublished results).
How might MAPK phosphorylation of Mos affect Mos
function? Substitution of Ser-3 with Ala, but not with Asp
or Glu, markedly reduces Mos stability during and after
progesterone-induced GVBD. Apparently, the negative
charge at residue 3 interferes with ubiquitin-mediated Mos
degradation (Nishizawa et al., 1992). MAPK phosphoryla-
tion at Ser-3 would therefore decrease Mos degradation,
leading to Mos accumulation rather than stimulation of
Mos synthesis. Since we only looked at labeled Mos 8 hr
after injection of thiophosphorylated MAPK (Fig. 4A; 50%
of the injected oocytes had undergone GVBD), the observed
Mos synthesis could be either an indirect result of activities
associated with GVBD or a direct result of enhanced protein
stability due to phosphorylation at Ser-3. In addition to de-
creasing Mos degradation, Ser-3 phosphorylation or Glu-3
substitution also promotes the physical association be-
tween Mos and MAPKK, including the activation of
MAPKK by Mos (Chen and Cooper, 1995). Thus, MAPK
phosphorylation of Mos at Ser-3 would enhance both pro-
tein stability and Mos kinase activity toward MAPKK.
The ability to test whether MAPK is a Mos kinase in
oocytes is hindered by the possibility that Ser-3 is a Mos
FIG. 4. MAPK induces Mos synthesis, and induction of GVBD by autophosphorylation site. For example, it is not clear how
Mos±MAPK coinjection or constitutively activated MAPKK re- signi®cant are the observations that Moskm is a poorer
quires de novo Mos synthesis. (A) 35S-labeled endogenous Mos MAPK substrate in vitro than is Moswt (Fig. 2A) and that
(pp39MosXe) was immunoprecipitated from oocytes that were un- Moskm phosphorylation in vivo, after progesterone-induced
treated (Stage VI, lane 1), progesterone-treated (lane 2), progester-
GVBD, is also less than that of Moswt (Nishizawa et al.,one-treated and immunoprecipitated in the presence of Mos com-
1992). This confusion carries over to the identi®cation ofpeting peptide (lane 3), injected with thiophosphorylated MAPK
Ser-3 as an autophosphorylation site. For example, the iden-(lane 4), injected with MBP-Moswt (1 ng, lane 5), or coinjected with
ti®cation is based in part upon analysis of Mos immunopre-MBP Moswt (1 ng)/active MAPK (6 ng) (lane 6). All extracts were
cipitates from 32P-labeled oocytes treated 12 hr with proges-made 8 hr after treatment (B and C). Stage VI oocytes were injected
with the indicated amounts of protein. Mos/MAPK* represents 1 terone and, therefore, containing activated MAPK. Nishi-
ng Mos/6 ng in vitro activated MAPK with or without injection of zawa et al. (1992) found that a Ser-3-containing peptide from
c-mos antisense (AS) or sense (S) oligonucleotides. Oligonucleotides Moskm was less phosphorylated than the equivalent peptide
were injected 1 hr before protein injection. MAPKK* represents 12 from Moswt, yet, the difference in 32P signals was small
ng constitutively activated MAPKK. Similar results were obtained enough that differential phosphorylation by MAPK is a for-
in three independent experiments.
mal possibility. Of course, in vivo phosphorylation of Ser-
3 by other kinases is also possible. Hyperphosphorylated
Moswt from 32P-labeled, post-GVBD oocytes exhibits the
same pattern of chymotryptic phosphopeptides as hypo-ble for catalyzing this event has not been identi®ed, al-
though it has been suggested that Ser-3 is a site of Mos phosphorylated Moskm from immature oocytes, which pre-
sumably contain no endogenous Mos (Freeman et al., 1992).autophosphorylation (see below). During maturation,
MAPK activation correlates temporally with Ser-3 phos- Whether or not Ser-3 is an autophosphorylation site, MAPK
must be considered a candidate for Ser-3 phosphorylationphorylation of Mos; that is, Ser-3 is hypophosphorylated
during early maturation and only becomes signi®cantly during and after GVBD.
How Mos becomes activated before GVBD remains un-phosphorylated during and after GVBD (Freeman et al.,
1992; Nishizawa et al., 1992). Interestingly, Mos Pro-4 is clear. The need to prevent precocious activation of Mos and
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tation of microgram quantities of protein utilizing the principleits downstream effectors could be met in part by regulation
of protein-dye binding. Anal. Biochem. 36, 201±212.of phosphorylation at Ser-3. This appears not to be the sole
Chen, M., and Cooper, J. A. (1995). Ser-3 is important for regulatingmechanism, however, since a mutant containing Ala at resi-
Mos interaction with and stimulation of mitogen-activated pro-due 3 (Mos3A) is capable of inducing progesterone-indepen-
tein kinase kinase. Mol. Cell. Biol. 15, 4727±4734.dent GVBD (Nishizawa et al., 1992; Freeman et al., 1992;
Daar, I., Paules, R. S., and Vande Woude, G. F. (1991). A character-
Chen and Cooper, 1995), albeit in our hands, MBP Mos3A is ization of cytostatic factor activity from Xenopus eggs and c-
30±40% less ef®cient than MBP Moswt (Matten and Vande mos-transformed cells. J. Cell Biol. 114, 32±35.
Woude, unpublished results). In addition, Ser-3 phosphory- Davis, R. J. (1993). The mitogen-activated protein kinase signal
lation may not be suf®cient for activation, since MBP MosE3 transduction pathway. J. Biol. Chem. 268, 14553±14556.
Drechsel, D., Hyman, A., Cobb, M., and Kirschner, M. (1992). Mod-is not active as a MAPKK kinase in vitro (Chen and Cooper,
ulation of the dynamic instability of tubulin assembly by the1995). The role of the other three serines phosphorylated in
microtubule-associated protein tau. Mol. Biol. Cell 3, 1141±vitro (Ser-16, -26, and -158) remains uncertain. As with
1154.MosA3, mRNAs for the MosA16 and MosA26 mutants retain
Drewes, G., Lichtenberg-Kraag, B., Doring, F., Mandelkow, E., Bier-the capacity to induce GVBD and act as CSF (Freeman et
nat, J., Goris, J., Doree, M., and Mandelkow, E. (1992). Mitogenal., 1992). MosA158 has not been tested for biological activity,
activated protein (MAP) kinase transforms tau protein into an
but is the only one of the four serines that is not conserved Alzheimer-like state. EMBO J. 11, 2131±2138.
among Xenopus, mouse, chicken, and human. It remains Erikson, E., and Maller, J. L. (1986). Puri®cation and characteriza-
possible that unidenti®ed members of the MAPK or cyclin tion of a protein kinase from Xenopus eggs highly speci®c for
cdk families, which are active earlier than the known mem- ribosomal protein S6. J. Biol. Chem. 261, 350±355.
Fabian, J., Morrison, D., and Daar, I. (1993). Requirement for Rafbers, participate in Mos activation.
and MAP kinase function during the meiotic maturation of Xeno-MAPK could perform several functions during normal
pus oocytes and eggs. Mol. Cell. Biol. 11, 1965±1971.meiotic maturation. MAPK appears to provide a link be-
Ferrell, J., Wu, M., Gerhart, J., and Martin, G. (1991). Cell cycletween Mos and activation of MPF, both at reentry into mei-
tyrosine phosphorylation of p34cdc2 and a microtubule-associatedosis I and during metaphase II arrest. This function may
protein kinase homolog in Xenopus oocytes and eggs. Mol. Cell.relate to MAPK's role in regulating microtubule dynamics
Biol. 11, 1965±1971.
(Gotoh et al., 1991b; Drechsel et al., 1992; Drewes et al., Freeman, R. S., Meyer, A. N., Li, J., and Donoghue, D. J. (1992).
1992). The results presented here describe an additional, Phosphorylation of conserved serine residues does not regulate
and compatible, role for MAPK. Synthesis of Mos, as well the ability of mosxe protein kinase to induce oocyte maturation
as other proteins, is required for progression from meiosis or function as cytostatic factor. J. Cell Biol. 116, 725±735.
Freeman, R. S., Pickham, K. M., Kanki, J. P., Lee, B. A., Pena, S. V.,I to metaphase arrest at meiosis II (Daar et al., 1991; Kanki
and Donoghue, D. S. (1989). Xenopus homolog of the mos pro-and Donoghue, 1991). Unlike MPF, MAPK remains active
tooncogene transforms mammalian ®broblasts and induces mat-during this period (Ferrell et al., 1991). Therefore, MAPK is
uration of Xenopus oocytes. Proc. Natl. Acad. Sci. USA 86, 5805±temporally positioned to enhance the accumulation of Mos,
5809.and possibly other proteins, that is required to achieve arrest
Gotoh, Y., Masoyama, N., Dell, K., Shirakabe, K., and Nishida, E.
at meiosis II. (1995). Initiation of Xenopus oocyte maturation by activation of
the mitogen-activated protein kinase cascade. J. Biol. Chem. 270,
25898±25904.
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